Recombinant cholera toxin B subunit activates dendritic cells and enhances antitumor immunity

Microbiology and Immunology

Volumn 49, Issue 1, 2005, Pages 79-87

  Isomura, Iwao ^a   Yasuda, Yoko ^a   Tsujimura, Kunio ^b   Takahashi, Toshitada ^b   Tochikubo, Kunio ^a   Morita, Akimichi ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cholera toxin B subunit; Dendritic Cells; Tumor immunity

Indexed keywords

CANCER VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CHOLERA TOXIN B SUBUNIT; GAMMA INTERFERON; INTERLEUKIN 12; RECOMBINANT CHOLERA TOXIN B SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOLOGY; CANCER INHIBITION; CANCER TRANSPLANTATION; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IMMUNOSTIMULATION; INTERFERON PRODUCTION; LYMPHOCYTE DEPLETION; MOUSE; NONHUMAN; VACCINATION; VACCINE PRODUCTION;

ANIMALIA; MURINAE;

EID: 14644407495     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2005.tb03632.x     Document Type: Article

References (31)

1. Acharton-Kerstien, T., Yu, J.M., Vassel, R., O'hagan, D., Alving, C.R., and Glenn, G.M. 2000. Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants. Infect. Immun. 68: 5306-5313.
2. Akira, S., Takeda, K., and Kaisho, T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675-680.
3. Banchereau, J., and Steinman, R.M. 1998. Dendritic cells and the control of immunity. Nature 392: 245-252.
4. Bell, D., Chromat, P., Broyles, D., Netto, G., Harb, G.M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K.A., and Banchereau, J. 1999. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas dendritic cells are located in peritumoral areas. J. Exp. Med. 190: 1417-1425.
5. Candido, K.A., Shimizu, K., McLaughlin, J.C., Kunkel, R., Fuller, J.A., Redman, E.G., Thomas, E.K., Nickoloff, B.J., and Mule, J.J. 2001. Local administration of dendritic cells inhibits established breast tumor growth: implications for apoptosis-inducing agents. Cancer Res. 61: 228-236.
6. Elson, C.O. 1996. Cholera toxin as a mucosal adjuvant, p. 59-72. In Mucosal vaccines, Academic Press, San Diego.
7. Fields, R.C., Shimizu, K., and Mule, J.J. 1998. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 95: 9482-9487.
8. George-Chandy, A., and Eriksson, K. 2001. Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect. Immun. 69: 5716-5725
9. Guidry, J.J., Cardenas, L., Cheng, E., and Clements, J.D. 1997. Role of receptor binding in toxicity, immunogenicity, and adjuvanticity of Escherichia coli heat-labile enterotoxin. Infect. Immun. 65: 4943-4950.
10. Haicheur, N., Bismuth, E., Bosset, S., Adotevi, O., Warnier, G., Lacabanne, V., Regnault, A., Desaymard, C., Amigorena, S., Ricciardi-Castagnoli, P., Goud, B., Fridman, W.H., Johannes, L., and Tartour, E. 2000. The B subunit of shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens. J. Immunol. 165: 3301-3308.
11. Hsu, F.J., Benike, C., and Fagnoni, F. 1996. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cell. Nat. Med. 2: 52-58.
12. Ichikawa, Y., Yamagata, H., Tochikubo, K., and Udaka, S. 1993. Very efficient extracellular production of cholera toxin B subunit using Bacillus brevis. FEMS Microbiol. Lett. 111: 219-224.
13. Jeannin, P., Renno, T., Goetsch, L., Miconnet, I., Aubry, J.P., Delneste, Y., Herbault, N., Baussant, T., Magistrelli, G., Soulas, C., Romero, P., Cerottini, J.C., and Bonnefoy, J.Y. 2000. OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway. Nat. Immunol. 1: 502-509.
14. Kugler, A., Stuhler, G., Walden, P., Zoller, G., Zobywalski, A., Brossait, P., Trefzer, U., Ullrich, S., Muller, C.A., Becker, V., Gross, A.J., Hemmerlein, B., Kanz, L., Muller, G.A., and Ringert, R.H. 2000. Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids. Nat. Med. 6: 332-336.
15. Livingston, P.O. 1995. Approaches to augmenting the immunogenicity of melanoma gangliosides: from whole melanoma cells to ganglioside-KLH conjugate vaccines. Immunol. Rev. 145: 145-166.
16. Lotze, M.T., Zitvogel, C., Campbell, R., Robbins, P.D., Elder, E., Haluszczak, C., Martin, C., Whiteside, T.L., Sturkus, W.J., and Tahara, H. 1996. Cytokine gene therapy of cancer using interleukin-12: murine and clinical trails. Ann. N.Y. Acad. Sci. 795: 440-454.
17. Lycke, N. 1997. The mechanism of cholera toxin adjuvanticity. 72nd forum in immunology. 504-520.
18. Maeyama, J., Isaka, M., Yasuda, Y., Matano, K., Kozuka, S., Taniguchi, T., Ohkuma, K., Tochikubo, K., and Goto, N. 2001. Cytokine responses to recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Microbiol. Immunol. 45: 111-117.
19. Murphy, O.P., Tjoa, B.A., Simmons, S.J., Ragde, H., Rodgers, M., Elgamal, A., Kenny, G.M., Troychak, M.J., Salgaller, M.L., and Boynton, A.L. 1999. Phase II prostate cancer vaccine trial: report of a study involving 37 patients with disease recurrence following primary treatment. Prostate 39: 54-59.
20. Nashar, T.O., Webb, H.M., Eaglestone, S., Williams, N.A., and Hirst, T. 1996. Potent immunogenicity of the B subunit of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad. Sci. U.S.A. 93: 226-230.
21. Nashar, T.O., Betterridge, Z.E., and Mitchell, R.N. 2001. Evidence for a role of ganglioside GM1 in antigen presentation: binding enhances presentation of Escherichia coli enterotoxin B subunit (EtxB) to CD4(+) T cells. Int. Immunol. 13: 541-551.
22. Nestle, P.O., Alijagic, S., Gillet, M., Sun, Y., Grabbe, S., Dummer, R., Burg, G., and Schadandorf, D. 1998. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat. Med. 4: 328-332.
23. Nishioka, Y., Hirao, M., Robbins, P.D., Lotze, M.T., and Tahara, H. 1999. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res. 59: 4035-4041.
24. Pardoll, D.M. 1998. Cancer vaccines. Nat. Med. 4: 525-531.
25. Porgador, A., Staats, H., Itoh, Y., and Kelsall, B.L. 1998. Intranasal immunization with cytotoxic T-lymphocyte epitope peptide and mucosal adjuvant cholera toxin: selective augmentation of peptide-presenting dendritic cells in nasal-mucosa-associated lymphoid tissue. Infect. Immun. 66: 5876-5881.
26. Sobel, D.O., Yankelevich, B., Goyal, D., Nelson, D., and Mazunder, A. 1998. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse. Diabetes 47: 186-191.
27. Tochikubo, K., Isaka, M., Yasuda, Y., Kozuka, S., Matano, K., Miura, Y., and Taniguchi, T. 1998. Recombinant cholera toxin B subunit acts as an adjuvant for mucosal and systemic responses of mice to mucosally co-administered bovine serum albumin. Vaccine 16: 150-155.
28. Tuting, T., DeLeo, A.B., Sturkus, W.J., and Lotze, M.T. 1997. Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or "self" antigens induce antitumor immunuty in vivo. Eur. J. Immunol. 27: 2702-2707.
29. Weiner, G.J. 2000. CpG DNA in cancer immunotherapy. Curr. Top. Microbiol. Immunol. 247: 157-170.
30. Wu, H.Y., and Russell, M.W. 1998. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant. Vaccine 16: 286-292.
31. Yankelevich, B., Brown, E., and Mazumder, A. 1995. Prevention of acute graft-versus-host disease by treatment with a novel immunosuppressant. Cholera toxin B subunit. J. Immunol. 154: 3611-3617.